On a disclosed annual basis, revenue went from KRW 885.5 billion in 2022 to KRW 771.7 billion in 2023, a 12.9% decline, then rose to KRW 776.4 billion in 2024 (up 0.6%) and KRW 884 billion in 2025 (up 13.9%). Among 2022 to 2025, 2022 was the largest year and 2023 the smallest.
Operating profit fell from KRW 186 billion in 2022 to KRW 124.1 billion in 2023 (down 33.3%), then rose to KRW 128.8 billion in 2024 (up 3.8%) and KRW 156.2 billion in 2025 (up 21.3%), increasing for two consecutive years from 2024 to 2025.
The operating margin dropped from 21.0% in 2022 to 16.1% in 2023 before recovering to 16.6% in 2024 and 17.7% in 2025. Profit attributable to controlling shareholders bottomed at KRW 105.3 billion in 2023 (down 32.1%) and then increased to KRW 122.7 billion in 2024 (up 16.5%) and KRW 147.3 billion in 2025 (up 20.1%).
Net income including non-controlling interests was KRW 148.1 billion in 2025, a different figure from profit attributable to controlling shareholders.
The debt ratio declined from 47.0% in 2022 to 35.9% in 2025, with total equity of KRW 1.18 trillion, controlling-shareholder equity of KRW 1.08 trillion, and total liabilities of KRW 423.1 billion at end-2025. Operating cash flow was KRW 200.4 billion in 2025, the highest of the 2022 to 2025 period.
On a quarterly basis, 3Q25 revenue was KRW 230 billion with operating profit of KRW 48.8 billion, then 4Q25 operating profit fell to KRW 16.9 billion (down 65.4% from the prior quarter).
Operating profit recovered to KRW 44.4 billion in 1Q26 (up 163.2% quarter on quarter), followed by KRW 49.8 billion in 2Q26 (up 12.0%) and KRW 48.5 billion in 3Q26 (down 2.4%).
DataDaily reported that first-quarter profit was pressured by higher oil-linked hydrogen peroxide raw material and freight costs and weaker QD demand.
DS Investment Securities said the completed peroxide price increase would let the company pass through the first-quarter cost loss starting in 2Q26. 3Q26 revenue of KRW 242.1 billion rose 5.2% year on year, but operating profit fell 0.5% year on year, so sales growth did not carry through to profit. Profit attributable to controlling shareholders over the last four quarters totaled KRW 152.9 billion.